Vyome Therapeutics Inc. is an innovation-driven, clinical stage speciality pharmaceutical dermatology focused company with a deep pipeline of novel therapeutics for antibiotic resistant C. acne and other opportunistic skin pathogens.
Vyome Therapeutics Completes Enrollment of Phase 2 Clinical Trial with VB-1953 in Moderate to Severe Inflammatory AcneView More
Read More to know about Vyome's Vision and PlansView More
Read More to know about Vyome's innovative and patented technology platforms for partnering opportunitiesView More
Read More to know about Vyome's pipeline of novel products developed using breakthrough technology platforms, and available for partneringView More
Team with expertise, demonstrated capability and track record of launching 50+ drugsView More
Read More to discover Partnering opportunities with Vyome on technology platforms and productsView More
Copyright © 2015 Vyome Therapeutics Inc. All rights reserved.